Search results for: 'research area cell cycle rock'
- A2173 SC 1441 CitationTarget: GlycoproteinsSummary: Gp130 inhibitor
- B5629 TAS 301Summary: inhibitor of smooth muscle cell migration and proliferation, inhibits PKC signaling
- P1024 IL-7, human recombinantSummary: IL-7, lymphoid cell growth factor, expressed in E.Coli, cross-species reactive.
- C3095 N-OxalylglycineSummary: cell permeable inhibitor of α-ketoglutarate-dependent enzymes, including JMJD2A, JMJD2C, and JMJD2E.
- BA1208 DCAPSummary: DCAP is a broad-spectrum antibiotic that targets the cell membranes of Gram-positive and Gram-negative bacteria.
- BA1893 TucaresolSummary: Tucaresol is an orally bioavailable immune-enhancing drug that enhances T helper cell activity.
- BA7728 BOS-318Summary: BOS-318 is a potent, slowly dissociating, highly selective, inhibitor of cell permeability.
- BA5856 AcazicolceptSummary: Azacicolcept (ALPN-101), an Fc fusion protein, is a dual inducible T cell co-stimulator/antagonist.
- BA5858 SolitomabSummary: Solitomab (AMG110) is a bispecific anti- and anti-epithelial cell adhesion molecule antibody.
- BA6019 PivekimabSummary: Pivekimab is available for the study of Bastoid Plasmacytoid Dendritic Cell Neoplasms (BPDCN).